======= ZNF207 ======= == Gene Information == * **Official Symbol**: ZNF207 * **Official Name**: zinc finger protein 207 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7756|7756]] * **UniProt**: [[https://www.uniprot.org/uniprot/O43670|O43670]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ZNF207&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ZNF207|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603428|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Kinetochore- and microtubule-binding protein that plays a key role in spindle assembly (PubMed:24462186, PubMed:24462187, PubMed:26388440). ZNF207/BuGZ is mainly composed of disordered low-complexity regions and undergoes phase transition or coacervation to form temperature-dependent liquid droplets. Coacervation promotes microtubule bundling and concentrates tubulin, promoting microtubule polymerization and assembly of spindle and spindle matrix by concentrating its building blocks (PubMed:26388440). Also acts as a regulator of mitotic chromosome alignment by mediating the stability and kinetochore loading of BUB3 (PubMed:24462186, PubMed:24462187). Mechanisms by which BUB3 is protected are unclear: according to a first report, ZNF207/BuGZ may act by blocking ubiquitination and proteasomal degradation of BUB3 (PubMed:24462186). According to another report, the stabilization is independent of the proteasome (PubMed:24462187). {ECO:0000269|PubMed:24462186, ECO:0000269|PubMed:24462187, ECO:0000269|PubMed:26388440}. No Pfam Domain information is available for this gene. |spindle matrix| |attachment of spindle microtubules to kinetochore| |mitotic spindle assembly checkpoint| |spindle checkpoint| |mitotic spindle checkpoint| |spindle assembly checkpoint| |negative regulation of mitotic metaphase/anaphase transition| |negative regulation of metaphase/anaphase transition of cell cycle| |negative regulation of mitotic sister chromatid separation| |negative regulation of chromosome separation| |negative regulation of mitotic sister chromatid segregation| |microtubule polymerization| |negative regulation of sister chromatid segregation| |negative regulation of chromosome segregation| |mitotic spindle assembly| |negative regulation of mitotic nuclear division| |negative regulation of nuclear division| |microtubule polymerization or depolymerization| |regulation of mitotic metaphase/anaphase transition| |regulation of metaphase/anaphase transition of cell cycle| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |regulation of mitotic sister chromatid segregation| |mitotic spindle organization| |regulation of sister chromatid segregation| |kinetochore| |protein polymerization| |condensed chromosome kinetochore| |microtubule bundle formation| |spindle assembly| |regulation of chromosome segregation| |microtubule cytoskeleton organization involved in mitosis| |mitotic sister chromatid segregation| |spindle| |negative regulation of chromosome organization| |sister chromatid segregation| |mitotic nuclear division| |mitotic cell cycle checkpoint| |spindle organization| |regulation of mitotic nuclear division| |heparin binding| |protein stabilization| |regulation of nuclear division| |cell cycle checkpoint| |negative regulation of mitotic cell cycle phase transition| |nuclear chromosome segregation| |negative regulation of cell cycle phase transition| |microtubule binding| |chromosome segregation| |nuclear division| |regulation of protein stability| |negative regulation of mitotic cell cycle| |organelle fission| |microtubule| |negative regulation of cell cycle process| |regulation of chromosome organization| |negative regulation of organelle organization| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |supramolecular fiber organization| |microtubule cytoskeleton organization| |cell division| |negative regulation of cell cycle| |mitotic cell cycle process| |regulation of mitotic cell cycle| |microtubule-based process| |DNA-binding transcription factor activity| |mitotic cell cycle| |negative regulation of cellular component organization| |regulation of cell cycle process| |organelle assembly| |zinc ion binding| |cellular protein-containing complex assembly| |nucleolus| |cell cycle process| |chromosome organization| |cytoskeleton organization| |regulation of cell cycle| |regulation of organelle organization| |cell cycle| |RNA binding| |DNA binding| |protein-containing complex assembly| |protein-containing complex subunit organization| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|1.7| |[[:results:exp279|D-Fructose 10000μM R06 exp279]]|1.73| |[[:results:exp374|Latrunculin-B 10μM R07 exp374]]|1.77| |[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.84| |[[:results:exp458|Bisphenol S 100μM R08 exp458]]|1.87| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|2| |[[:results:exp467|CAY10603 0.55μM R08 exp467]]|2.02| |[[:results:exp400|Senexin-A 25μM R07 exp400]]|2.03| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|2.16| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|2.17| |[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|2.19| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|2.23| |[[:results:exp512|Olaparib 4μM R08 exp512]]|2.24| |[[:results:exp444|THZ531 0.225μM R08 exp444]]|2.26| |[[:results:exp144|PFI-3 10μM R03 exp144]]|2.38| |[[:results:exp180|Dynasore 10μM R04 exp180]]|2.42| |[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|2.63| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|3.44| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 339/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|7/28| |blood|19/28| |bone|9/26| |breast|17/33| |central nervous system|22/56| |cervix|1/4| |colorectal|8/17| |esophagus|5/13| |fibroblast|0/1| |gastric|6/16| |kidney|15/21| |liver|6/20| |lung|35/75| |lymphocyte|6/16| |ovary|13/26| |pancreas|6/24| |peripheral nervous system|11/16| |plasma cell|13/15| |prostate|0/1| |skin|16/24| |soft tissue|3/9| |thyroid|1/2| |upper aerodigestive|9/22| |urinary tract|17/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1741 * **Expression level (log2 read counts)**: 8.48 {{:chemogenomics:nalm6 dist.png?nolink |}}